Tetraphase Pharmaceuticals IPO Research Information

Tetraphase Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Tetraphase Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Tetraphase Pharmaceuticals	TTPH -	$10.00-$12.00	$7.00	$7.20	10.7 million	3/20/2013
Underwriter(s): Barclays, BMO Capital Markets
Co-Manager(s): Stifel, JMP Securities, Needham & Company
Industry: Health Care
Filing(s): Filed 2013-02-11

Tetraphase Pharmaceuticals Quote & Chart - Click for current quote - TTPH

About Tetraphase Pharmaceuticals (adapted from Tetraphase Pharmaceuticals prospectus):
They are a clinical stage biopharmaceutical company using our proprietary chemistry technology to create novel antibiotics for serious and life-threatening multi-drug resistant infections.

This description is adapted from Tetraphase TTPH prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Tetraphase TTPH "TTPH" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.